Workshop on Informed Consent in HIV Prevention Trials

艾滋病毒预防试验知情同意研讨会

• 批准号: 6940557
• 负责人: BARBARA A FRIEDLAND
• 金额: $ 0.6万
• 依托单位: POPULATION COUNCIL
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-03-01 至 2006-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6940557
• 关键词: AIDS education /prevention; clinical trials; education evaluation /planning; ethics; health care service planning; informed consent; meeting /conference /symposium; travel

DESCRIPTION (provided by applicant): Description, location and dates: The Population Council and Family Health International are convening a workshop on informed consent in clinical trials of HIV prevention technologies in developing countries. The three-day meeting will be held at the Population Council headquarters in New York City in the spring of 2005. Types of participants: Participants will include researchers implementing clinical trials (microbicides, vaccines, etc.); experts in risk communication, development and evaluation of behavior change communication (BCC) materials, and contraceptive introduction; members of organizations such as the International. AIDS Vaccine Initiative (IAVI), the Alliance for Microbicides Development, the Global Campaign for Microbicides, and the International Partnership for Microbicides (IPM); and key donors. Goals: Given the increasing number of HIV prevention trials planned or underway, and the ethical and practical challenges inherent in conducting these trials, it is critical to ensure that participants are truly informed and enroll voluntarily. Our goal is to review current practices and to outline recommendations for improving the informed consent process, including developing a framework for evaluation. Topics to be covered: We will review existing educational materials (booklets, flip-charts, videos), techniques for assessing comprehension (such as comprehension quizzes), and strategies for evaluating the materials and processes before and during the trials; explore ways in which the community can help (or hinder) the informed consent process; identify concepts that are typically problematic (such as placebo, randomization, and "partial effectiveness") and explore ways to improve communication about these.

描述（由申请人提供）：描述，位置和日期：人口委员会和国际家庭卫生委员会正在召集有关发展中国家艾滋病毒预防技术临床试验的知情同意讲习班。为期三天的会议将于2005年春季在纽约市的人口委员会总部举行。 参与者的类型：参与者将包括实施临床试验的研究人员（菌皮，疫苗等）；风险交流，开发和评估行为变更沟通（BCC）材料以及避孕介绍方面的专家；国际组织等组织的成员。艾滋病疫苗倡议（IAVI），微生物发展联盟，全球菌心运动和国际微生物伙伴关系（IPM）；和关键捐助者。目标：鉴于计划或正在进行的艾滋病毒预防试验越来越多，以及进行这些试验所固有的道德和实践挑战，至关重要的是要确保参与者真正了解和自愿参加。我们的目标是审查当前的做法并概述改善知情同意程序的建议，包括开发评估框架。 要涵盖的主题：我们将审查现有的教育材料（小册子，翻盖，视频），评估理解的技术（例如理解测验）以及在试验之前和期间评估材料和流程的策略；探索社区可以帮助（或阻碍）知情同意程序的方式；确定通常有问题的概念（例如安慰剂，随机化和“部分有效性”），并探索改善有关这些沟通的沟通的方法。